Spots Global Cancer Trial Database for ONO-4538 Phase I Study in Patients With Solid Tumor
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: ONO-4538 Phase I Study in Patients With Solid Tumor
Official Title: ONO-4538 Multicenter, Open-label, Uncontrolled, Phase I Multiple Dose Study in Solid Tumor
Study ID: NCT02261298
Interventions
Study Description
Brief Summary: The objective of this study is to investigate the safety, pharmacokinetics, pharmacology and efficacy of ONO-4538 administered to Korean patients with advanced or recurrent solid tumors who are refractory or intolerant to standard therapy or for whom no appropriate treatment is available.
Detailed Description:
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Seongnam-si Clinical Site 105, Seongnam-si, Gyeonggi-do, Korea, Republic of
Seoul Clinical Site 101, Seoul, , Korea, Republic of
Seoul Clinical Site 102, Seoul, , Korea, Republic of
Seoul Clinical Site 103, Seoul, , Korea, Republic of
Seoul Clinical Site 104, Seoul, , Korea, Republic of
Contact Details
Name: Mitsunobu Tanimoto
Affiliation: Ono Pharmaceutical Co. Ltd
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
